Skip to main content

Closed

STOK: Stoke Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+316.3% / yr

Operating margin-577.5%

ROIC-45.4%

Financially safe

Stretched

Debt / equity0.01×

Interest coverage-54.4×

Current ratio8.99×

Stoke Therapeutics, Inc.

STOKNASDAQ Global Select·USD·Closed

Stoke Therapeutics, Inc.

STOKNASDAQ·USD·Closed

$28.86

−3.93%

$28.86

−$1.18 (3.93%)

52W Range

59thpctl

Volume

0.94×avg

Mkt Cap

1.80BUSD

P/E

-10.2TTM

Div Yield

–ann

52W Range

59thpctl

Volume

0.94×avg

Market Cap

1.80BUSD

P/E Ratio

-10.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings